Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Palliation of hepatic metastases: results of the radiation therapy oncology group pilot study. [X-ray]

Journal Article · · Int. J. Radiat. Oncol., Biol. Phys.; (United States)
 [1]; ; ; ;
  1. Thomas Jefferson Univ., Hospital, Philadelphia, PA
From May, 1976, to July, 1978, 20 Radiation Therapy Oncology Group (RTOG) institutions participated in a prospective, uncontrolled, non-randomized pilot study designed to gain information regarding the feasibility of hepatic irradiation for the treatment of symptomatic liver metastases. One hundred-three of 109 patients who entered were included in the present analysis. Eligible patients included those with hepatic metastases from solid, non-hematologic tumors documented by liver scan. Patients with solitary liver metastases received either 3040 rad/19 fractions or 3000 rad/15 fractions followed by an optional 2000 rad/10 fractions boost to residual disease. Nausea and/or vomiting was induced or aggravated in 16%. There were no documented cases of radiation-induced hepatitis, nephritis or pneumonitis. Improvement of liver function chemistries occurred in 40% and palpable liver mass was reduced in 49%. The results of this study indicate that rapid courses of whole liver irradiation are well-tolerated with good therapeutic benefit in patients with symptomatic liver metastases.
OSTI ID:
6454294
Journal Information:
Int. J. Radiat. Oncol., Biol. Phys.; (United States), Journal Name: Int. J. Radiat. Oncol., Biol. Phys.; (United States) Vol. 7:5; ISSN IOBPD
Country of Publication:
United States
Language:
English